Check out CRN's latest press releases in our feed, or search for your topics of interest. Members of the media, learn more here about working with CRN for science-based information for your reporting.
Observance of February as Heart Month can be a reminder of the cost-saving potential of evidence-backed dietary supplements to help reduce the health impacts—and the healthcare costs—of coronary artery disease. The CRN Foundation’s recent Health Care Cost Savings report, Supplement to Savings (“S2S”), identified up to $17.74 billion in annual net savings if specific dietary supplements (omega-3 fatty acids, magnesium, vitamin K2 and soluble fiber) are used by the at-risk target populations most susceptible to coronary artery disease (CAD). The study, commissioned by the CRN Foundation and conducted by Frost & Sullivan, provides analysis on the risk reduction effects supplementation can have on specific chronic illnesses or diseases, including CAD. The Foundation announced the overall findings including insights on the analysis in August 2022.
Read more
Read more